Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MFG Chemical is a leading specialty chemical contract development and manufacturing organization (CDMO) that provides custom synthesis and manufacturing services. The company specializes in complex chemistries, including amidation, esterification, and polymerization, serving the pharmaceutical, personal care, and industrial markets. With manufacturing facilities in Georgia and Texas, MFG Chemical offers capabilities ranging from pilot-scale development to full commercial production. The company is particularly noted for its expertise in maleic anhydride derivatives and high-pressure reactions. Since its acquisition by Platte River Equity in 2017, MFG Chemical has expanded its capacity to support global customers in the life sciences and specialty chemical sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MFG Chemical.